Antitumor Activity of HM781-36B, an Irreversible EGFR/HER-2 Inhibitor Highly Effective in EGFR-dependent Cancer Models Including Erlotinib-Resistant NSCLC
HomeAntitumor Activity of HM781-36B, an Irreversible EGFR/HER-2 Inhibitor Highly Effective in EGFR-dependent Cancer Models Including Erlotinib-Resistant NSCLC
HomeAntitumor Activity of HM781-36B, an Irreversible EGFR/HER-2 Inhibitor Highly Effective in EGFR-dependent Cancer Models Including Erlotinib-Resistant NSCLC
Antitumor Activity of HM781-36B, an Irreversible EGFR/HER-2 Inhibitor Highly Effective in EGFR-dependent Cancer Models Including Erlotinib-Resistant NSCLC
저자
Cha, M.Y.; Lee, K.-O.; Kim, M.; Chae, Y.J.; Song, J.Y.; Lee, G.H.; Kim, Y.H.; Suh, K.H.; Park, S.B.*; Kim, M.S.*
